Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Nyctar AB
AB
Active
Org 5594000191
Kista Gårdsväg 20, 164 55
Kista
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2022
2 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Nyctar AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
1M
2M
2M
2M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2024
0M
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
2 212
635
Staff expenses
−719
−684
EBITDA
600
−66
Depreciation & amort.
−17
−98
EBIT
582
−163
Net financials
−0
0
Profit before tax
582
−163
Tax
−122
—
Net profit
460
−163
Balance sheet
SEK thousands
Item
2024
2025
Total assets
797
545
Equity
485
72
Long-term debt
—
—
Short-term debt
312
473
Total debt
312
473
Financial ratios
5-year trend
EBITDA margin
-10.4%
This company
15.8%
Market median
-166% vs market
2024
2025
Equity ratio
13.2%
This company
38.2%
Market median
-65% vs market
2024
2025
Return on equity
-227.6%
This company
18.4%
Market median
-1337% vs market
2024
2025
Net profit margin
-25.7%
This company
8.1%
Market median
-417% vs market
2024
2025
Asset turnover
1.17×
This company
1.12×
Market median
+4% vs market
2024
2025
Debt / equity
6.60×
This company
0.62×
Market median
-965% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-02-01 – 2025-01-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2022-10-04 – 2024-01-31
View
PDF
More on Nyctar AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
